Tongue Cancer in Cats: Palliative Chemo May Help Eating

A case report in one senior Persian cat with advanced tongue cancer found that electrochemotherapy was associated with reduced tumor burden, less oral pain, and preserved voluntary eating, even with hidden regional spread — highlighting the potential of palliative care to maintain quality of life.

Journal: Frontiers in Veterinary Science
Sample Size: 1 senior Persian cat
Study Type: Case report
Published: 2026-07-20
Species:

Key Findings

  • Electrochemotherapy reduced visible tumor burden and oral pain.
  • The treatment preserved voluntary feeding despite hidden regional spread of the cancer.

When Mouth Cancer Takes Away a Cat’s Ability to Eat

Cat tongue cancer treatment is one of the hardest topics a pet owner can face. Oral tumors don’t just threaten a cat’s life — they often steal the simple daily pleasure of eating and drinking long before the disease reaches its final stage. A new case report in Frontiers in Veterinary Science describes one senior Persian cat with advanced tongue cancer whose ability to keep eating was preserved after a targeted treatment called electrochemotherapy.

Electrochemotherapy is a technique that pairs a tiny dose of a chemotherapy drug with brief electrical pulses to drive the drug directly into tumor cells. The result, in this single case, was a reduction in tumor size and oral pain — and a cat that continued eating voluntarily despite hidden cancer spread that imaging had not fully captured.

This is one patient’s story, not a large clinical trial. But for owners whose cats face a mouth cancer diagnosis, it illustrates what palliative care can sometimes achieve.

What Exactly Is Electrochemotherapy?

The name sounds intimidating, but the concept is straightforward. Normally, cancer cells have a tough outer wall that keeps most chemotherapy drugs out. Electrochemotherapy uses a short burst of electricity — delivered through small probes placed around the tumor — to briefly create tiny openings in those outer walls. A low dose of chemotherapy drug is injected into the tumor at that exact moment, flooding through the now-open doors and destroying the cells from within.

Think of it like briefly unlocking a lock rather than smashing the whole door. Because the drug goes directly into the tumor rather than circulating through the whole body, the chemotherapy dose needed is much smaller — and the side effects are typically far milder than with traditional systemic (whole-body) chemotherapy.

Electrochemotherapy has been used in human oncology for decades. It is increasingly studied in veterinary medicine as both a curative and palliative option for accessible tumors in cats and dogs.

About the Cat in This Case

The case involved a single senior Persian cat with advanced tongue cancer. Persian cats — known for their flat faces and long, silky coats — were the breed involved here. By the time the cat was treated, the disease had progressed significantly.

Key details about the case:

  • Subject: 1 senior Persian cat
  • Condition: Advanced tongue cancer
  • Treatment: Electrochemotherapy, delivered as palliative care (comfort-focused, not intended to cure)
  • Study type: Case report — a detailed description of one patient’s treatment and outcome
  • What was monitored: Visible tumor burden, oral pain levels, and whether the cat continued eating voluntarily

Because this is a case report with a single patient, all findings represent observations from one animal. No comparison group existed.

What the Treatment Achieved

The veterinary team reported two meaningful outcomes after electrochemotherapy:

Tumor reduction and pain relief. The treatment visibly reduced the size of the tongue tumor and was associated with a decrease in oral pain. Mouth tumors are notoriously painful — they can make every attempt to eat feel like swallowing fire. Even a partial reduction in tumor bulk can make a significant difference in comfort.

Preserved voluntary eating. Despite the cancer having spread beneath the surface lining of the mouth in ways that had not been fully detected by staging (the process of measuring how far the disease has spread), the cat continued eating and drinking on its own after treatment. This is particularly notable because cancer spread that hides under the surface — called submucosal spread — can be missed on imaging, meaning the disease may be further along than scans suggest. The cat’s ability to eat persisted in spite of this.

Together, these findings point to what palliative care is designed to accomplish: not eliminating the disease, but reducing suffering and keeping daily function — like eating — intact for as long as possible.

What Cat Owners Facing Oral Cancer Should Know

If your cat has been diagnosed with tongue or mouth cancer, this case highlights a few important points.

Palliative care is a real and valid treatment path. You do not have to choose between aggressive curative treatment and doing nothing. Palliative options focus on comfort, pain control, and function. For cats with advanced cancer who may not tolerate — or benefit from — major surgery or full-course chemotherapy, a palliative approach can still meaningfully improve quality of life.

Imaging may underestimate how far the cancer has spread. This case noted that staging — CT scans, imaging studies — may not reveal submucosal spread of oral tumors. If your vet or oncologist is assessing the extent of your cat’s cancer, asking about the limits of imaging in the mouth can help you understand the full picture.

Electrochemotherapy is a specialist procedure. Not every veterinary clinic offers it. If you are interested in exploring ECT as an option, ask for a referral to a board-certified veterinary oncologist. They can evaluate whether your cat is a candidate and discuss how ECT compares to other palliative options such as pain management protocols, laser therapy, or radiation.

Watch for early signs that eating is becoming difficult. Cats are good at hiding discomfort. Reduced interest in food, dropping food while eating, pawing at the mouth, or drooling more than usual are all signs that oral pain may be worsening — and a reason to contact your vet promptly.

The Limits of This Research

A single case report is the smallest unit of evidence in veterinary medicine. It cannot tell us:

  • How often electrochemotherapy produces these results in other cats with tongue cancer
  • Which cats are most likely to respond
  • How the benefit compares to other palliative treatments
  • How long the improvement in eating and pain control lasts

Case reports are valuable for surfacing possibilities and informing future research, but they cannot replace controlled studies with many patients. Larger prospective studies following multiple cats with oral cancer would be needed before drawing broader conclusions about electrochemotherapy as a palliative option.

The authors also noted that conventional staging may underestimate submucosal disease — an important caution for any cat undergoing oral cancer evaluation.

The Bottom Line

A case report published in Frontiers in Veterinary Science describes one senior Persian cat with advanced tongue cancer whose oral pain decreased and whose ability to eat voluntarily was preserved after electrochemotherapy. The treatment was palliative — aimed at comfort, not cure — and delivered meaningful quality-of-life benefits even in the presence of hidden cancer spread.

This is a single animal’s experience, and results cannot be generalized. But it reinforces that palliative care for cats with oral cancer can be a worthwhile goal. If your cat has been diagnosed with a mouth or tongue tumor, a conversation with a veterinary oncologist about all palliative options — including electrochemotherapy — is a step worth taking.


This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.

Reference

Electrochemotherapy Helped One Cat With Tongue Cancer Keep Eating. (2026). Frontiers in Veterinary Science. DOI: https://doi.org/10.3389/fvets.2026.1850098